A functional γδTCR/CD3 complex distinct from γδT cells is expressed by human eosinophils

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Legrand, Fanny ^a,b,c   Driss, Virginie ^a,b,c   Woerly, Gaëtane ^a,b,c   Loiseau, Sylvie ^a,b,c   Hermann, Emmanuel ^a,b,c   Fournié, Jean Jacques ^a   Héliot, Laurent ^b,c,d   Mattot, Virginie ^b,c,d   Soncin, Fabrice ^b,c,d   Gougeon, Marie Lise ^e   Dombrowicz, David ^a,b,c   Capron, Monique ^a,b,c  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d INSTITUT DE BIOLOGIE DE LILLE   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYTOKINE; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; GAMMA INTERFERON; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR NECROSIS FACTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL LINEAGE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; EOSINOPHIL; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; INNATE IMMUNITY; MYCOBACTERIUM BOVIS; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SPECTROSCOPY; TUMOR CELL; BIOSYNTHESIS; CYTOLOGY; FLOW CYTOMETRY; METABOLISM; MICROBIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE PROPERTY; T LYMPHOCYTE;

CORYNEBACTERINEAE;

ANTIGENS, CD3; EOSINOPHIL PEROXIDASE; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM BOVIS; REACTIVE OXYGEN SPECIES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURFACE PROPERTIES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650155617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005926     Document Type: Article

References (67)

1. Giembycz MA, Lindsay MA (1999) Pharmacology of the eosinophil. Pharmacol Rev 51: 213-340.
2. Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24: 147-174.
3. Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, et al. (2008) Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 205: 699-710.
4. Walsh ER, Sahu N, Kearley J, Benjamin E, Kang BH, et al. (2008) Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med 205: 1285-1292.
5. Young JD, Peterson CG, Venge P, Cohn ZA (1986) Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321: 613-616.
6. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, et al. (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367: 183-186.
7. Stenfeldt AL, Wenneras C (2004) Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 112: 605-614.
8. Jacobsen EA, Taranova AG, Lee NA, Lee JJ (2007) Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 119: 1313-1320.
9. Kayaba H, Dombrowicz D, Woerly G, Papin JP, Loiseau S, et al. (2001) Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J Immunol 167: 995-1003.
10. Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, et al. (1999) Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by Immunoglobulin A complexes. J Exp Med 190: 487-495.
11. Woerly G, Lacy P, Younes AB, Roger N, Loiseau S, et al. (2002) Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol 72: 769-779.
12. Melo RC, Spencer LA, Dvorak AM, Weller PF (2008) Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. J Leukoc Biol 83: 229-236.
13. Lucey DR, Nicholson-Weller A, Weller PF (1989) Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A 86: 1348-1351.
14. Seton K, Hakansson L, Carlson M, Stalenheim G, Venge P (2003) Apoptotic eosinophils express IL-2R chains alpha and beta and co-stimulatory molecules CD28 and CD86. Respir Med 97: 893-902.
15. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF (2000) Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 105: 945-953.
16. Plumas J, Gruart V, Aldebert D, Truong MJ, Capron M, et al. (1991) Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit. Eur J Immunol 21: 1265-1270.
17. Simon HU, Plotz S, Simon D, Seitzer U, Braathen LR, et al. (2003) Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. Eur J Immunol 33: 834-839.
18. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF (1989) Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med 169: 327-332.
19. Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, et al. (2005) 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol 174: 110-118.
20. Rowley AF, Page M (1985) Ultrastructural, cytochemical and functional studies on the eosinophilic granulocytes of larval lampreys. Cell Tissue Res 240: 705-709.
21. Svensson L, Redvall E, Bjorn C, Karlsson J, Bergin AM, et al. (2007) House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. Eur J Immunol 37: 1966-1977.
22. Miike S, McWilliam AS, Kita H (2001) Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J Immunol 167: 6615-6622.
23. Bolton SJ, McNulty CA, Thomas RJ, Hewitt CR, Wardlaw AJ (2003) Expression of and functional responses to protease-activated receptors on human eosinophils. J Leukoc Biol 74: 60-68.
24. Driss V, Legrand F, Hermann E, Loiseau S, Guerardel Y, et al. (2008) TLR2-dependent eosinophil interactions with mycobacteria : role of alpha-defensins. Blood in press.
25. Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, et al. (2003) Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol 171: 3977-3982.
26. Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, et al. (2007) Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110: 1578-1586.
27. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, et al. (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14: 949-953.
28. Tepper RI, Coffman RL, Leder P (1992) An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257: 548-551.
29. Tepper RI (1994) The eosinophil-mediated antitumor activity of interleukin-4. J Allergy Clin Immunol 94: 1225-1231.
30. Brandes M, Willimann K, Moser B (2005) Professional antigen-presentation function by human gammadelta T Cells. Science 309: 264-268.
31. Hayday AC (2000) Gamma delta cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 18: 975-1026.
32. Carding SR, Egan PJ (2002) Gamma delta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2: 336-345.
33. Metso T, Venge P, Haahtela T, Peterson CG, Seveus L (2002) Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects. Thorax 57: 449-451.
34. Puellmann K, Kaminski WE, Vogel M, Nebe CT, Schroeder J, et al. (2006) A variable immunoreceptor in a subpopulation of human neutrophils. Proc Natl Acad Sci U S A 103: 14441-14446.
35. Boullier S, Poquet Y, Halary F, Bonneville M, Fournie JJ, et al. (1998) Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vgamma9 Vdelta2 T cells but not on CD94- thymic or mature gammadelta T cell clones. Eur J Immunol 28: 3399-3410.
36. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, et al. (1994) Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264: 267-270.
37. Espinosa E, Belmant C, Pont F, Luciani B, Poupot R, et al. (2001) Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells. J Biol Chem 276: 18337-18344.
38. Thompson K, Rojas-Navea J, Rogers MJ (2006) Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood 107: 651-654.
39. Lasco TM, Turner OC, Cassone L, Sugawara I, Yamada H, et al. (2004) Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun 72: 1147-1149.
40. Groh V, Steinle A, Bauer S, Spies T (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279: 1737-1740.
41. Hayday A, Tigelaar R (2003) Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3: 233-242.
42. Rand TH, Silberstein DS, Kornfeld H, Weller PF (1991) Human eosinophils express functional interleukin 2 receptors. J Clin Invest 88: 825-832.
43. Krejci O, Prouzova Z, Horvath O, Trka J, Hrusak O (2003) Cutting edge: TCR delta gene is frequently rearranged in adult B lymphocytes. J Immunol 171: 524-527.
44. Fronkova E, Krejci O, Kalina T, Horvath O, Trka J, et al. (2005) Lymphoid Differentiation Pathways Can Be Traced by TCR {delta} Rearrangements. J Immunol 175: 2495-2500.
45. Couedel C, Lippert E, Bernardeau K, Bonneville M, Davodeau F (2004) Allelic exclusion at the TCR delta locus and commitment to gamma delta lineage: different modalities apply to distinct human gamma delta subsets. J Immunol 172: 5544-5552.
46. Shigematsu H, Reizis B, Iwasaki H, Mizuno S, Hu D, et al. (2004) Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 21: 43-53.
47. Kawamoto H (2006) A close developmental relationship between the lymphoid and myeloid lineages. Trends Immunol 27: 169-175.
48. Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell 117: 663-676.
49. Sehmi R, Denburg JA (2000) Differentiation of human eosinophils. Role in allergic inflammation. Chem Immunol 76: 29-44.
50. Lee JJ, Lee NA (2005) Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? Clin Exp Allergy 35: 986-994.
51. de Andres B, Rakasz E, Hagen M, McCormik ML, Mueller AL, et al. (1997) Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 89: 3826-3836.
52. Decot V, Woerly G, Loyens M, Loiseau S, Quatannens B, et al. (2005) Heterogeneity of expression of IgA receptors by human, mouse, and rat eosinophils. J Immunol 174: 628-635.
53. Jameson J, Havran WL (2007) Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol Rev 215: 114-122.
54. O'Brien RL, Roark CL, Jin N, Aydintug MK, French JD, et al. (2007) Gammadelta T-cell receptors: functional correlations. Immunol Rev 215: 77-88.
55. Hsu SY, Hsu HF, Mitros FA, Helms CM, Solomon RI (1980) Eosinophils as effector cells in the destruction of Schistosoma mansoni eggs in granulomas. Ann Trop Med Parasitol 74: 179-183.
56. Choy MY, Walker-Smith JA, Williams CB, MacDonald TT (1990) Activated eosinophils in chronic inflammatory bowel disease. Lancet 336: 126-127.
57. Borelli V, Vita F, Shankar S, Soranzo MR, Banfi E, et al. (2003) Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis. Infect Immun 71: 605-613.
58. Thedrez A, Sabourin C, Gertner J, Devilder MC, Allain-Maillet S, et al. (2007) Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? Immunol Rev 215: 123-135.
59. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, Aljama A (2000) Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 88: 1544-1548.
60. Bennouna J, Bompas E, Neidhardt EM, Rolland F, Philip I, et al. (2008) Phase-I study of Innacell gammadeltatrade mark, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 57: 1599-1609.
61. Legrand F, Woerly G, Driss V, Capron M (2007) Innate immune functions of eosinophils. From antiparasite to antitumor cells. In: Ewbank J, Vivier E, eds. Methods in molecular Biology. Totowa NJ: Humana Press. pp 215-240.
62. Plager DA, Loegering DA, Checkel JL, Tang J, Kephart GM, et al. (2006) Major basic protein homolog (MBP2): a specific human eosinophil marker. J Immunol 177: 7340-7345.
63. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR (2006) Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7: 681-685.
64. Hayes SM, Love PE (2002) Distinct structure and signaling potential of the gamma delta TCR complex. Immunity 16: 827-838.
65. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
66. Douillard P, Josien R, Pannetier C, Bonneville M, Soulillou JP, et al. (1998) Selection of T cell clones with restricted TCR-CDR3 lengths during in vitro and in vivo alloresponses. Int Immunol 10: 71-83.
67. Wilkinson DG, Nieto MA (1993) Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts. Methods Enzymol 225: 361-373.